ETF收评：恒生创新药ETF领涨4.08%，信创50ETF领跌3.76%

Group 1 - The ETF market showed mixed performance, with the Hang Seng Innovative Drug ETF (159316) leading gains at 4.08% [1] - The Hong Kong Innovative Drug ETF (159567) increased by 3.81%, while the Hong Kong Stock Connect Innovative Drug ETF (159570) rose by 3.69% [1] - On the downside, the Xinchuang 50 ETF (560850) led losses at 3.76%, followed by the Xinchuang ETF Fund (562030) which fell by 3.68%, and the Xinchuang ETF (562570) decreased by 3.21% [1] Group 2 - A-share accounts can now buy Hong Kong stocks with T+0 trading without the need for Hong Kong Stock Connect [1]